IKT - Financial Reports List - Inhibikase Therapeutics, Inc. - IntrinsicAlpha

Inhibikase Therapeutics, Inc. IKT

Healthcare - Biotechnology - NASDAQ - US

$ 1.68

-8.7 %

$ 125 M

Market Cap

-1.45

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	0.00%	-190.40%	-193.60%
Annual Report	FY	10-K	2024-12-31	0.00%	-44.62%	-42.31%
Quarterly Report	Q3	8-K	2024-09-30	0.00%	-25.74%	-22.20%
Quarterly Report	Q2	8-K	2024-06-30	0.00%	14.16%	18.57%
Quarterly Report	Q1	8-K	2024-03-31	0.00%	-16.14%	-1.43%
Quarterly Report	Q4	8-K	2023-12-31	-100.00%	-0.26%	-1.58%
Annual Report	FY	10-K	2023-12-31	111.03%	-6.28%	-10.82%
Quarterly Report	Q3	8-K	2023-09-30	0.00%	-2.24%	-5.67%
Quarterly Report	Q2	8-K	2023-06-30	1676.71%	-24.53%	-33.67%
Quarterly Report	Q1	8-K	2023-03-31	40.17%	13.73%	-1.60%

1